Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Advanced Nursing|February 1, 1995
Communication in nursing: the theory-practice relationshipM L Brereton
Clinical and Laboratory Haematology|November 26, 2005
Digital imaging of haematological morphologyC V Hutchinson, M L Brereton, J Burthem
British Journal of Haematology|February 23, 1999
The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEGrHuMGDF) on megakaryopoiesis in patients with aplastic anaemiaM L Brereton, J A Adams, M Briggs, et al.
Blood|April 21, 2001
Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemiaB D Harrison, J A Adams, M Briggs, et al.
British Journal of Haematology|January 31, 1998
Expression of AML1/MTG8 transcripts in clonogenic cells grown from bone marrow of patients in remission of acute myeloid leukaemia with t(8;21)M J Saunders, M L Brereton, J A Adams, et al.
Clinical and Laboratory Haematology|March 1, 1995
Immunostaining of whole agar cultures by APAAPR Burgess, K Hyde, H Lenehan, et al.
British Journal of Haematology|November 14, 1997
The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on megakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukaemiaJ A Adams, J A Liu Yin, M L Brereton, et al.
British Journal of Haematology|May 3, 2000
Megakaryopoiesis in vitro in myelodysplastic syndromes and acute myeloid leukaemia: effect of pegylated recombinant human megakaryocyte growth and development factor in combination with other growth factorsJ A Liu Yin, J A Adams, M L Brereton, et al.
British Journal of Haematology|December 12, 2001
Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemiaM Briggs, J A Adams, M L Brereton, et al.
British Journal of Haematology|October 1, 1996
The effect of the chemokine rhMIP-1 alpha, and a non-aggregating variant BB-10010, on blast cells from patients with acute myeloid leukaemiaP J Owen-Lynch, J A Adams, M L Brereton, et al.
Pageof 2